Diagnostic molecular microbiology. A 2013 snapshot.

Clinics in Laboratory Medicine

Volumn 33, Issue 4, 2013, Pages 787-803

  Fairfax, Marilynn Ransom ^a   Salimnia, Hossein ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

MALDI TOF; Molecular microbiology; Multiplex PCR panels; Nuclear magnetic resonance; PCR; Probe tests; Rapid molecular diagnosis of infections

Indexed keywords

ASSAY; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DIAGNOSTIC EQUIPMENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC PROCEDURES; HUMAN; HYBRID CAPTURE TECHNIQUE; HYBRIDIZATION PROTECTION ASSAY; INFECTION; LABORATORY DEVICE; MASS SPECTROMETER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL IDENTIFICATION; MICROBIOLOGY; MOLECULAR DIAGNOSTICS; MOLECULAR PROBE; MULTIPLEX POLYMERASE CHAIN REACTION; NEXTGEN SEQUENCING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEIC ACID AMPLIFICATION; PEPTIDE NUCLEIC ACID FLUORESCENCE IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE;

MALDI TOF; MOLECULAR MICROBIOLOGY; MULTIPLEX PCR PANELS; NUCLEAR MAGNETIC RESONANCE; PCR; PROBE TESTS; RAPID MOLECULAR DIAGNOSIS OF INFECTIONS;

COMMUNICABLE DISEASES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR PROBE TECHNIQUES; MOLECULAR TYPING; PATHOLOGY, MOLECULAR;

EID: 84888166454     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2013.08.003     Document Type: Review

References (56)

1. Alexander B.D., Ashley E.D., Reller L.B., et al. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 2006, 54:277-282.
2. Forrest G.N., Roghmann M.C., Toombs L.S., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008, 52:3558-3563.
3. Perez K.K., Olsen R.J., Musick W.L., et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2013, 137:1247-1254. Accessed September 12, 2013.
4. Karlsson F.H., Fak F., Nookaew I., et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012, 3:1245. Accessed September 12, 2013. 10.1038/ncomms2266.
5. AccuProbe Mycobacterium tuberculosis complex culture identification test. Package Insert. Hologic Gen-Probe. Revision 2011-02. Accessed on line April 28, 2013. Available at:. http://www.gen-probe.com/pdfs/pi/102896RevN.pdf.
6. García-Garrote F., Ruiz-Serrano M.J., Cosín J., et al. Mycobacterium celatum as a cause of disseminated infection in an AIDS patient. A case report and review of the literature. Clin Microbiol Infect 1997, 3:582-584.
7. Welch D.F., Guruswamy A.P., Sides S.J., et al. Timely culture for mycobacteria which utilizes a microcolony method. JClin Microbiol 1993, 31:2178-2184.
8. Becton Dickinson. Bacte Myco/F Sputa. Package Insert. Revision 2010/2. Accessed on line 4/20/2013. Available at:. http://www.bd.com/ds/technicalCenter/inserts/PP101JAA(2011002).pdf.
9. Lie A.K., Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 2008, 8:405-415.
10. Qiagen. Digene Hybrid Capture 2 High-Risk HPV DNA Test. Ref 5199-1220. Package insert. Accessed on line 5/2/2013. Available at:. Accessed September 9, 2013. http://www.qiagen.com/resources/Download.aspx%3Fid=(0A98CB57-25B9-48A9-9C4F-4C66D1CDA47C)%26lang=en%26ver=5.
11. Gravitt E., Rostich A.F., Silver M.I., et al. Acohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. JInfect Dis 2013, 207:274-280. Queried on line 4/2/2013.
12. Quiroga-Garza G., Zhou H., Mody D.R. Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype?. Arch Pathol Lab Med 2013, [Epub ahead of print]. 10.5858/arpa.2012-0640-OA.
13. Bayer. Versant HIV-1 RNA 3.0 Assay (bDNA) Package Insert. Queried on line 4/28/2013.
14. Baumeister M.A., Zhang N., Beas H., et al. Asensitive branched DNA HIV-1 signal amplification viral load technique with a single day turnaround. PLoS One 2012, 7:e33295. queried on line 4/26/2013. 10.1371/journal.pone.0033295.
15. Salimnia H., Moore E.C., Crane L.R., et al. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) standard and ultrasensitive assays caused by freezing patient plasma in centrifuged Becton-Dickinson vacutainer brand plasma preparation tubes. JClin Microbiol 2005, 43:4635-4639.
16. Fairfax M.R., Salimnia H. Beware of unusual organisms masquerading as skin contaminants. Sepsis-an ongoing and significant challenge 2012, 275-286. Intech Open, Rijeka (Croatia). L. Azevedo (Ed.).
17. Becton Dickinson. BD Affirm VPIII Microbial Identification Test. Package Insert. Revision of 2006/02 Queried on line 04/25/2013. Available at:. http://www.bd.com/ds/technicalCenter/inserts/pkgInserts.asp#PF8.
18. Bhargava A, Mitchell R, Painter T, etal. Co-infections based upon DNA Homology: Two years experience at a Tertiary Medical Centre. Presented at ICAAC 2012. San Francisco, September 9-12, 2012.
19. Andrea S.B., Chapin K.C. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiologic implications. JClin Microbiol 2011, 49:866-869.
20. Gen-Probe. Aptima Combo 2 Assay. Package Insert. Version 2011-04. Queried on line: 05/20/2013. Available at:. http://www.gen-probe.com/pdfs/pi/501799-EN-RevD.pdf.
21. Taylor S.N., Van der Pol B., Lillis B., et al. Clinical evaluation of the BD ProbeTec Chlamydia trachomatis Qx amplified DNA assay on the BD Viper system with XTR technology. Sex Transm Dis 2011, 38:603-609.
22. Cook R.L., Hutchison S.L., Ostergaard L., et al. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005, 142:915-925.
23. Becton Dickinson. ProbeTec Chlamydia trachomatis (CT) Qx Amplified DNA assay. Package insert. Version 2010/12. queried on line 5/12/2013. Available at:. http://www.bd.com/ds/technicalCenter/inserts/8981498(201012).pdf.
24. Tabrizi S.N., Unemo M., Limnios A.E., et al. Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. JClin Microbiol 2011, 49:3610-3615.
25. Cheng A., Qian Q., Kirby J.E. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cpbas Amplicor CT/NG Assay. JClin Microbiol 2011, 49:1294-1300.
26. Schacter J., Moncada J., Liska S., et al. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008, 35:637-642.
27. Moller J.K., Pedersen L.N., Persson K. Comparison of the Abbott RealTime CT new formulation assay with two other commercial assays for the detection of wild-type and new variant strains of Chlamydia trachomatis. JClin Microbiol 2010, 48:440-443.
28. Won H., Ramachandran P., Steece R., et al. Is there evidence of the new variant Chlamydia trachomatis in the United States. Sex Transm Dis 2013, 40:352-353.
29. Centers for Disease Control and Prevention Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012, 61:590-594.
30. BD. ProbeTec Herpes Simplex Viruses (HSV 1 & 2) QxAmplified DNA Assays. Version 2012/10. Queried on line 5/20/2013. Available at:. http://www.bd.com/ds/technicalCenter/inserts/8086121(01).pdf.
31. Gen-Probe. Gen-Probe Procleix Ultrio Plus Assay. 502432-REG Rev.7, as submitted to the FDA. Queried on line 5/20/2013. Available at:. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM335285.pdf.
32. Maurin M. Real-time PCR as a diagnostic tool for bacterial diseases. Expert Rev Mol Diagn 2012, 12:731-754.
33. Fairfax M.R., Salimnia H. Quantitative PCR: an introduction. Handbook of molecular diagnostics 2010, 3-14. Academic Press, London, UK. W.W. Grody, C. Strom, F.L. Kiechle (Eds.).
34. Espy M.J., Uhl P., Mitchell S., et al. Diagnosis of herpes simplex virus in the clinical laboratory by LightCycler PCR. JClin Microbiol 2000, 38:795-799.
35. Issa N.C., Espy M.J., Uhl P., et al. Sequencing and resolution of amplified herpes simplex virus with intermediate melting curves as genotype 1 or 2 by light cycler PCR assay. JClin Microbiol 2005, 43:1843-1845.
36. Available at:. Accessed May 12, 2013. http://www.luminexcorp.com/prod/groups/public/documents/lmnxcorp/342-multicode-tech.pdf.
37. Salimnia H., Lephart P.R., Asmar B.I., et al. Aerosolized vaccine as an unexpected source of false positive Bordetella pertussis PCR Results. JClin Microbiol 2012, 50:472-474.
38. Strain M.C., Richmond D.D. New assays for monitoring residual HIV burden in effectively treated individuals. Curr Opin HIV AIDS 2013, 8:106-110.
39. Sire J.M., Vray M., Merzouk M., et al. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. JAcquir Immune Defic Syndr 2011, 56(3):239-243.
40. Wojewoda C.M., Shalinger T., Harmon M.L., et al. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV monitoring and follow-up of low-level viral loads. JVirol Methods 2013, 187:1-5.
41. Babady N.E., Mead P., Stiles J., et al. Comparison of the Luminex xTAG RVP FastAssay with the Idaho Technology FilmArray RP Assay for detection of respiratory viruses in pediatric patients at a cancer hospital. JClin Microbiol 2012, 50:2282-2288.
42. McGrath E.J., Thomas R., Asmar B., et al. Detection of respiratory co-infections in pediatric patients using a small volume polymerase chain reaction array respiratory panel: more evidence for combined droplet and contact isolation. Am J Infect Control 2013, 41:868-873. Queried on line 4/1/2013.
43. Popowich E.B., O'Niel S.S., Miller M.M. Comparison of the Biofire FilmArray RP, Genmark eSensor RBP, Luminex xTAG RVPv1, and Luminex xTAG RVP Fastmultiplex assays for detection of respiratory viruses. JClin Microbiol 2013, 51(5):1528-1533. Accessed 5/16/2012. 10.1128/JCM.03368-12.
44. Mahoney J.B. Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther 2010, 8(11):1273-1292. Available at:, Accessed May 16, 2013. http://dx.doi.org/10.1586/eri.10.121.
45. de Groot R.J., Baker S.C., Baric R.S., et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV); announcement of the coronavirus study group. JVirol 2013, 87:7790-7792. queried on 5/20/2013. 10.1128/JVI.0244-13.
46. Liu F., Shi W., Shi Y., et al. Origin and diversity of novel influenza A7N9 viruses causing human infection; phylogenetic, structural and coalescent analyses. Lancet 2013, 381:1926-1932. Accessed 5/21/13.
47. Capobianchi M.R., Giombini E., Rozera G. Next-generation sequencing technology in clinical virology. Clin Microbiol Infect 2013, 19(1):15-22. 10.1111/1469-0691.12056.
48. Song S., Jarvie T., Hattori M. Our second genome-human metagenome: how next-generation sequencer changes our life through microbiology. Adv Microb Physiol 2013, 62:119-144. 10.1016/B978-0-12-410515-7.00003-2.
49. Sherry N.L., Porter J.L., Seemann T., et al. Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. JClin Microbiol 2013, 51:1396-1401. 10.1128/JCM.03332-12.
50. Theel E.S., Schmitt B.H., Hall L., et al. Formic acid-based direct, on-plate testing of yeast and corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2012, 50:3093-3095. 10.1128/JCM.01045-12.
51. March-Rosselló G.A., Muñoz-Moreno M.F., García-Loygorri-Jordán de Urriés M.C., et al. Adifferential centrifugation protocol and validation criterion for enhancing mass spectrometry (MALDI-TOF) results in microbial identification using blood culture growth bottles. Eur J Clin Microbiol Infect Dis 2013, 32:699-704. 10.1007/s10096-012-1797-1.
52. Wimmer J.L., Long S.W., Cernoch P., et al. Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. JClin Microbiol 2012, 50(7):2452-2454.
53. Rehse S.J., Salimnia H., Miziolek A.W., et al. Laser-induced breakdown spectroscopy (LIBS): an overview of recent progress and future potential for biomedical applications. JMed Eng Technol 2012, 36:77-89.
54. Hamasha K., Mohaidat Q.I., Putnam R.A., et al. Sensitive and specific discrimination of pathogenic and nonpathogenic Escherichia coli using Raman spectroscopy-a comparison of two multivariate analysis techniques. Biomed Opt Express 2013, 4:481-489.
55. Chung H.J., Castro C.M., Im H., et al. Amagneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria. Nat Nanotechnol 2013, 8:369-375. Accessed 5/20/2013. 10.1038/nnano.2013.70.
56. Liong M., Hoang A.N., Chung J., et al. Magnetic barcode assay for genetic detection of pathogens. Nat Commun 2013, 4. Accessed 5/19/2013. 10.1038/ncomms2745.